Status:
UNKNOWN
NORVIT and WENBIT - Long-term Follow-up
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
University of Tromso
Norwegian Foundation for Health and Rehabilitation
Conditions:
Cancer
Myocardial Infarction
Eligibility:
All Genders
27-86 years
Brief Summary
Two large homocysteine-lowering B-vitamin intervention trials have been performed in Norway during the period 1998 to 2005, NORVIT and WENBIT. The main objective in these trials was to study the clini...
Detailed Description
The "homocysteine-hypothesis" of vascular disease has attracted considerable interest, as total plasma homocysteine levels can be easily lowered by folic acid and vitamin B12, raising the prospect tha...
Eligibility Criteria
Inclusion
- Randomised in the Norwegian Vitamin Trial (NORVIT) or in the Western Norway B-Vitamin Intervention Trial (WENBIT)
Exclusion
- Withdrawn consent to participate in study cohort for post-trial observational follow-up
Key Trial Info
Start Date :
December 1 1998
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
6839 Patients enrolled
Trial Details
Trial ID
NCT00671346
Start Date
December 1 1998
End Date
January 1 2021
Last Update
November 5 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Heart Disease, Haukeland University Hospital
Bergen, Norway, 5021
2
University of Tromsø
Tromsø, Norway, 9037